{"id":"W4391838925","doi":"10.1038/s41409-024-02207-4","title":"Ruxolitinib in patients with graft versus host disease (GvHD): findings from a compassionate use program","year":2024,"lang":"en","type":"article","venue":"Bone Marrow Transplantation","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Novartis (Canada)","funders":"Novartis Pharmaceuticals Canada; Novartis Pharma","keywords":"Ruxolitinib; Medicine; Internal medicine; Graft-versus-host disease; Gastroenterology; Corticosteroid; Disease; Myelofibrosis; Bone marrow","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001074872,0.0002717449,0.0003052067,0.0002856572,0.00005658135,0.0001101695,0.00005919666,0.0001049246,0.0002183315],"category_scores_gemma":[0.00001815299,0.0002288345,0.00008693238,0.0004067428,0.00006494362,0.0003855558,0.00000442715,0.0002416572,0.00007985182],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001193729,"about_ca_system_score_gemma":0.0001435579,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002047122,"about_ca_topic_score_gemma":0.0001312938,"domain_scores_codex":[0.9980639,0.00006707929,0.0004268929,0.0005065604,0.0005997932,0.0003358021],"domain_scores_gemma":[0.9991091,0.0003090593,0.00004344793,0.0002100815,0.00007304834,0.0002552847],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02857826,0.001358472,0.9477916,0.003427569,0.0002534856,0.003166887,0.003563709,0.00004585737,0.001704416,0.0008257099,0.0002035114,0.009080493],"study_design_scores_gemma":[0.01018456,0.000340491,0.9852237,0.001602938,0.0005756352,0.00001136752,0.00004483837,0.0006460464,0.0007192955,0.00004455858,0.0003299789,0.0002765763],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957961,0.0001128526,0.0005051417,0.0003552756,0.0003585865,0.001497051,0.0006827066,0.0003257066,0.0003665735],"genre_scores_gemma":[0.9916791,0.00007620766,0.002087058,0.00006694195,0.00003960191,0.0002000442,0.00568023,0.00005910094,0.0001117226],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03743209,"threshold_uncertainty_score":0.9331601,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01680985862668637,"score_gpt":0.2631552878661827,"score_spread":0.2463454292394963,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}